
Bioorganic and Medicinal Chemistry Letters p. 1613 - 1618 (1998)
Update date:2022-08-03
Topics:
Weber, Ingo R.
Neidlein, Richard
Von Der Saal, Wolfgang
Grams, Frank
Leinert, Herbert
Strein, Klaus
Engh, Richard A.
Kucznierz, Ralf
Based on the structures of aminopyridine thrombin inhibitors (1), a series of aminoalkyl- and guanidinoalkyl-substituted diarylsulfonamides were prepared. The most potent derivative, N-[3-(4-guanidinobutoxy)-5-methyl- phenyl]-benzenesulfonamide (6c) had Ki = 0.18 μM for thrombin and did not inhibit trypsin, plasmin, or factor Xa. Comparison of the X-ray structures of the thrombin / 1b and the thrombin / 6e complexes revealed important aspects which govern the binding of such diarylsulfonamides to thrombin.
View Morewebsite:http://www.hope-chem.com
Contact:86-21-58090396-805
Address:Floor 4, Building 5, No.588 Tianxiong Road, Zhoupu International Medical Zone, ShangHai, China
Wuhan Chemchemical Co., Ltd.(expird)
Contact:15973022782
Address:7-5-6218,Incubation Centre,Guandong Industry Park, East Lake High-Tech Development Zone,Wuhan City.
LIANYUNGANG YC FINE CHEMICAL CO., LTD
Contact:+86-518-858 99188
Address:Shangdong Modern Bldg, South Greenpark Road, Lianyungang, Jiangsu Pro. China
Contact:+86-21-38228826
Address:Room 505 Building 2, No 3377 Kangxin Highway, Shanghai, Republic China
Hefei EnliPharma Tecnology Co.,Ltd
Contact:0086-551-66399836
Address:Qing Cheng ShuiXiang Building 805, Mengcheng North Road , ShuangFeng Economic Development Zone Anhui HeFei
Doi:10.1002/ejic.201601475
(2017)Doi:10.1002/jhet.5570360142
(1999)Doi:10.1016/S0040-4020(01)96847-4
(1968)Doi:10.1021/om980066r
(1998)Doi:10.1055/s-1998-2126
(1998)Doi:10.1016/S0040-4039(98)01142-3
(1998)